Sernova Biotherapeutics Incis A Clinical Stage Biotechnology Company Based In Canadadedicated To Advancing Regenerative Medicine For Chronic Diseasesfounded In 1998Sernova Focuses On Developing Innovative Technologies That Enhance Cell Therapy Deliveryaiming To Replicate Natural Body Functionsthe Company Seeks Partnerships With Other Firms In The Regenerative Medicine Field To Co Develop And Commercialize Its Products The Company S Primary Asset Is The Cell Pouch Systema Bio Hybrid Organ Designed To Create A Supportive Environment For Therapeutic Cellsthis System Is Currently Being Tested In Clinical Trials For Conditions Like Type 1 Diabetes And Hypothyroidismsernova Is Also Collaborating With Evotec To Develop Induced Pluripotent Stem Cell Based Treatments For Insulin Dependent Diabeteswith A Strong Focus On Chronic Diseasessernova Is Positioned For Significant Growth In The Multibillion Dollar Regenerative Medicine Market
